Jazz Pharmaceuticals plc — Director's Dealing 2019

Dec 7, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2019-12-04

Reporting Person: O'Keefe Kenneth W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-04	Ordinary Shares	S	6750	$147.8184	Disposed	4445	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	5644	Direct

Footnotes

F1: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.77 to $148.05. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F2: Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.